NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
UCL Institute of Ophthalmology, London, UK.
Eye (Lond). 2019 Jun;33(6):910-916. doi: 10.1038/s41433-019-0338-x. Epub 2019 Jan 24.
To assess the rate of change in macular drusen load in fellow eyes of patients with unilateral neovascular age-related macular degeneration (AMD) to evaluate whether the change in drusen load determines the onset and type of choroidal neovascularisation (CNV).
Subjects with unilateral neovascular AMD with a minimum of 2 years follow-up were identified retrospectively from the hospital electronic database. Drusen count, area and volume measurements at the macula of the contralateral eye were recorded using the commercial software on the Topcon 3D OCT-2000 devices over the previous 2 years. The mean rate of change of these parameters over time was compared between fellow eyes that converted to various CNV subtypes and those that did not.
Two hundred forty-eight patients met the inclusion criteria. Of these patients, 179 patients did not progress to neovascular AMD (Group 1) while 69 patients converted (Group 2) at the end of 2 years follow up. Mean drusen volumes and drusen areas increased significantly in Group 2 in the 2nd year by 0.031 mm (p < 0.001) and 0.572 mm (p = 0.002), respectively. However, there was no difference in the rate of change between the two groups at year 1. Furthermore, for each 0.1 mm increase in the cubed root of baseline mean drusen volume increases the odds of progressing to CNV by 40% (95% CI 1.2-1.6; p < 0.001). The increase in drusen volume was higher in the occult CNV group compared to classic CNV (p = 0.048).
A significant increase in mean drusen volume occurs in eyes in the preceding 12 months prior to conversion to neovascular AMD and this change is more significant in eyes with occult CNV.
评估单侧新生血管性年龄相关性黄斑变性(AMD)患者对侧眼黄斑部玻璃膜疣负荷的变化率,以评估玻璃膜疣负荷的变化是否决定脉络膜新生血管(CNV)的发生和类型。
从医院电子数据库中回顾性地确定单侧新生血管性 AMD 伴至少 2 年随访的患者。使用 Topcon 3D OCT-2000 设备上的商业软件,在过去 2 年内记录对侧眼黄斑部的玻璃膜疣计数、面积和体积测量值。比较这些参数在不同时间点的平均变化率,以确定是否转换为各种 CNV 亚型。
248 例患者符合纳入标准。其中,179 例患者未进展为新生血管性 AMD(组 1),69 例患者在 2 年随访结束时转化为新生血管性 AMD(组 2)。组 2 患者在第 2 年玻璃膜疣体积和面积分别显著增加了 0.031mm(p<0.001)和 0.572mm(p=0.002)。然而,两组在第 1 年的变化率没有差异。此外,基线平均玻璃膜疣体积的立方根每增加 0.1mm,进展为 CNV 的几率增加 40%(95%CI 1.2-1.6;p<0.001)。隐匿型 CNV 组的玻璃膜疣体积增加高于经典型 CNV 组(p=0.048)。
在向新生血管性 AMD 转变前的 12 个月内,对侧眼的平均玻璃膜疣体积显著增加,而隐匿型 CNV 眼的变化更为显著。